Showing results (91-100 of 1,877) with videos related to

Sort By:
Pageof 188
Immunotherapy|February 25, 2021
Emerging advances in cationic liposomal cancer nanovaccines: opportunities and challengesMohammad Z Ahmad, Javed Ahmad, Mohammed Y Alasmary, et al.
Immunotherapy|March 31, 2017
Bioinformatic prediction and experimental validation of a PE38-based recombinant immunotoxin targeting the Fn14 receptor in cancer cellsMaryam Keshtvarz, Jafar Salimian, Mehdi Yaseri, et al.
Immunotherapy|April 13, 2017
Pembrolizumab in recurrent advanced cervical squamous carcinomaPablo Martínez, Josep María Del Campo
Immunotherapy|November 11, 2021
Delayed immune-related neutropenia with hepatitis by pembrolizumabSoichiro Nakako, Yasuhiro Nakashima, Hiroshi Okamura, et al.
Immunotherapy|November 11, 2021
Venous thromboembolism events in patients with advanced cancer on immune checkpoint inhibitorsAdi Kartolo, Cynthia Yeung, Gordon T Moffat, et al.
Immunotherapy|November 8, 2021
Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case reportGuido Pesola, Veronica Murianni, Sara Elena Rebuzzi, et al.
Immunotherapy|December 6, 2021
The combination of immune checkpoint inhibitors and chemotherapy in advanced non-small-cell lung cancer: the rational choiceJoseph Zouein, Fady G Haddad, Roland Eid, et al.
Immunotherapy|September 4, 2019
Validation of immunogenic PASD1 peptides against HLA-A*24:02 colorectal cancerJoanne Ec Soh, Nadiah Abu, Ismail Sagap, et al.
Immunotherapy|August 30, 2019
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancerJohannes Doescher, Stephanie E Weissinger, Stefan S Schönsteiner, et al.
Immunotherapy|August 30, 2019
Myasthenia gravis induced by avelumabCarlen Yuen, Gini Fleming, Michael Meyers, et al.
Pageof 188